Ikaros and tumor suppression in acute lymphoblastic leukemia.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3243972)

Published in Crit Rev Oncog on January 01, 2011

Authors

Kimberly J Payne1, Sinisa Dovat

Author Affiliations

1: Loma Linda University, Loma Linda, California, USA.

Articles citing this

A proteome-scale map of the human interactome network. Cell (2014) 3.91

Cancer subtype discovery and biomarker identification via a new robust network clustering algorithm. PLoS One (2013) 0.89

ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leuk Res (2013) 0.82

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression. Blood (2014) 0.80

Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans. Sci Rep (2014) 0.79

A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells. Stem Cell Reports (2014) 0.78

Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. J Virol (2014) 0.78

A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. PLoS One (2013) 0.77

Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis. PLoS One (2015) 0.77

Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21). Clin Proteomics (2014) 0.77

Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review. Int J Environ Res Public Health (2012) 0.76

Targeting of Heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL. Oncotarget (2016) 0.75

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia. Curr Cancer Drug Targets (2013) 0.75

Principles of microRNA Regulation Revealed Through Modeling microRNA Expression Quantitative Trait Loci. Genetics (2016) 0.75

Ikaros6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemia. Int J Clin Exp Med (2015) 0.75

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia. Haematologica (2017) 0.75

Articles cited by this

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12

Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature (2007) 5.65

Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell (1997) 5.62

Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol (2009) 5.22

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet (2009) 4.47

Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet (2009) 3.71

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood (2010) 3.66

Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J (1996) 3.18

The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol (1994) 3.15

Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J (1999) 3.11

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia (2007) 2.85

Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science (1992) 2.77

Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity (2007) 2.65

High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis. Blood (2002) 2.47

LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol Cell Biol (1991) 2.41

Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol (2008) 2.40

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia (2010) 2.17

Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol (2006) 2.09

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol (2009) 2.00

The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99

An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol (2000) 1.97

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood (2010) 1.86

Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem (2000) 1.81

The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell (2002) 1.79

The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol (1997) 1.78

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood (2009) 1.76

Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels. Leuk Lymphoma (2008) 1.72

Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. Cancer Cell (2003) 1.71

Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol (2004) 1.53

A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains. Genes Dev (2002) 1.53

Ikaros SUMOylation: switching out of repression. Mol Cell Biol (2005) 1.48

Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2beta determine silencer activity and Cd4 gene expression. Immunity (2007) 1.45

Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem (2009) 1.43

Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol Cell Biol (2010) 1.42

Ikaros represses the transcriptional response to Notch signaling in T-cell development. Mol Cell Biol (2008) 1.33

Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem (2008) 1.29

Unconventional potentiation of gene expression by Ikaros. J Biol Chem (2002) 1.25

Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J (2001) 1.25

Genetic inactivation of Ikaros is a rare event in human T-ALL. Leuk Res (2009) 1.24

Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev (2001) 1.24

Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res (1999) 1.23

Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing. Genome Res (2009) 1.22

Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia (2010) 1.22

Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage. Blood (2001) 1.19

Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation. J Biol Chem (2008) 1.14

Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res (2000) 1.12

Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene. Mol Cell Biol (1993) 1.10

A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol (1996) 1.10

A wide role for NOTCH1 signaling in acute leukemia. Cancer Lett (2005) 1.06

Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem (2006) 1.06

Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res (1999) 1.03

Upstream of Ikaros. Trends Immunol (2003) 0.96

Assembly of silent chromatin during thymocyte development. Semin Immunol (2005) 0.94

Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene. Pediatr Blood Cancer (2011) 0.92

Submicroscopic deletions in 5q- associated malignancies. Haematologica (2004) 0.92

Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res (2009) 0.89

Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells. Mol Endocrinol (2006) 0.88

Ikaros isoforms: The saga continues. World J Biol Chem (2011) 0.85

Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia. Exp Hematol (2002) 0.85

Overexpression of the Ikaros 6 isoform is restricted to t(4;11) acute lymphoblastic leukaemia in children and infants and has a role in B-cell survival. Br J Haematol (2004) 0.84

Articles by these authors

Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem (2009) 1.43

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proc Natl Acad Sci U S A (2012) 1.30

Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem (2008) 1.29

IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol (2009) 1.28

Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing. Genome Res (2009) 1.22

Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood (2011) 1.12

Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem (2006) 1.06

Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene. Pediatr Blood Cancer (2011) 0.92

Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res (2009) 0.89

Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1. World J Biol Chem (2011) 0.87

Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer (2011) 0.85

Ikaros isoforms: The saga continues. World J Biol Chem (2011) 0.85

Severe congenital protein C deficiency: description of a new mutation and prophylactic protein C therapy and in vivo pharmacokinetics. J Pediatr Hematol Oncol (2008) 0.84

Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia. Pediatr Blood Cancer (2014) 0.83

Genetic targets in pediatric acute lymphoblastic leukemia. Adv Exp Med Biol (2013) 0.82

Induction of senescence by adenosine suppressing the growth of lung cancer cells. Biochem Biophys Res Commun (2013) 0.81

Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros. J BUON (2014) 0.79

Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. J Virol (2014) 0.78

Angiogenesis and survival in patients with myelodysplastic syndrome. Pathol Oncol Res (2012) 0.76

AMID mediates adenosine-induced caspase-independent HuH-7 cell apoptosis. Cell Physiol Biochem (2011) 0.75

Corrigendum: Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia. Sci Rep (2017) 0.75